SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-216008
Filing Date
2019-08-08
Accepted
2019-08-08 07:11:53
Documents
64
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d765310d10q.htm 10-Q 783461
2 EX-31.1 d765310dex311.htm EX-31.1 6274
3 EX-31.2 d765310dex312.htm EX-31.2 6261
4 EX-32.1 d765310dex321.htm EX-32.1 3866
5 EX-32.2 d765310dex322.htm EX-32.2 3853
  Complete submission text file 0001193125-19-216008.txt   5408417

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srra-20190630.xml EX-101.INS 1534682
7 XBRL TAXONOMY EXTENSION SCHEMA srra-20190630.xsd EX-101.SCH 36707
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20190630_cal.xml EX-101.CAL 36871
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20190630_def.xml EX-101.DEF 122947
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20190630_lab.xml EX-101.LAB 333740
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20190630_pre.xml EX-101.PRE 240954
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 191007443
SIC: 2834 Pharmaceutical Preparations